Skip to main content
Premium Trial:

Request an Annual Quote

New Bioinformatics Software Library is Java-Based

Premium

COLD SPRING HARBOR, N.Y.--Bioinformatics software provider Oxford Molecular Group and Glaxo Wellcome have unveiled a new, jointly developed Java-based bioinformatics software library on the worldwide web. Designed to provide public access to software, databases, and on-line resources for the storage, retrieval, and analysis of genetic information, it is located at http://www.oxmol.com/OM-GW-Lib/.

The library initially contains two Java applets that can be used to access genetic databases: one showing a physical genetic map of the human genome, and the other providing a graphical interface to six different genomic databases. The applets should run under any Java-enabled browser, according to Oxford.

Mark Cortelyou, Oxford's bioinformatics business development manager, said the two companies will continue to develop additional web-based tools for bioinformatics applications, with several more expected this year. They will be available at no cost for academic use; commercial users can buy them for use on internal networks.

Filed under

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.